Bioprocess Engineering

Special Issue

Advances in Biochemical Engineering and Biotechnology

  • Submission Deadline: Jun. 25, 2020
  • Status: Submission Closed
  • Lead Guest Editor: Peter Blas
About This Special Issue
This special issue will review the current research available around the world about Gene therapy. It will explain what gene therapy is available to the general public and explain how difficult is it for the FDA to pass AAV gene therapies. It will also explain how the bioprocessing of AAV is achieved, and take the reader into what the drawbacks are in industry and biomanufacturing? It will highlight the current gene therapies on the market, and why more are not available. It will finish with what the future may hold for gene therapy.

Aims and Scope:

  1. Gene therapy review
  2. Biomanufacturing
  3. Accessibility
  4. Current therapies available
  5. Drawbacks to gene therapy
  6. Future Challenges
Lead Guest Editor
  • Peter Blas

    Department of Science, The Kibworth School, Leicester, United Kingdom

Published Articles
  • The Use of a Shear Device to Monitor the Stability of a Single-Chain Variable Fragment (scFv) Fusion Protein MFECP1

    Peter Blas

    Issue: Volume 4, Issue 1, June 2020
    Pages: 29-39
    Received: Mar. 17, 2020
    Accepted: Apr. 22, 2020
    Published: May 29, 2020
    DOI: 10.11648/
    Abstract: Antibody based drugs are increasingly being used to treat a vast array of diseases because of their unique affinity to target specific antigen proteins on the surfaces of target cancer cells. Fusions of antibodies and conjugated biopharmaceuticals are progressively being used as this gives the opportunity to target other cytotoxic molecules to unwa... Show More